Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
03/2006
03/22/2006EP1636169A1 Method for dehydrating substituted 4-dimethylamino-2-aryl-butan-2-ol compounds and method for producing substituted dimethyl-(3-aryl-butyl)-amine compounds by means of heterogeneous catalysis
03/22/2006EP1636159A1 Method for the treatment or prevention of lower urinary tract symptoms
03/22/2006EP1250314B1 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicides
03/22/2006EP1020426B9 Amine derivatives and process for producing the same
03/22/2006CN1751019A Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
03/22/2006CN1246319C Amino (thio) ether derivative
03/22/2006CN1245874C Agrochemical compositions and surfactant compounds
03/21/2006USRE39030 Fluoxetine enteric pellets and methods for their preparation and use
03/21/2006US7014699 reacting polyepoxides with amines to form surfactants used as dispersants for oragnic or inorganic pigments
03/21/2006CA2181366C Hydrogenation catalyst, process for the preparation thereof and hydrogenation process
03/21/2006CA2124932C Sex steroid activity inhibitors
03/16/2006WO2006029303A2 Diphenyl ether derivatives and their use for imaging serotonin transporters
03/16/2006WO2006027684A1 Therapeutic diphenyl ether ligands
03/16/2006WO2006027039A1 P-diaminobenzole-derivatives and dyes containing said compounds
03/16/2006WO2005056499A3 Oligo(p-phenylene vinylene) amphiphiles and methods for self-assembly
03/16/2006US20060058542 Phosphine compound, its intermediate, its complex with palladium and a manufacturing method of unsaturated compounds by using the palladium complex
03/16/2006US20060058391 Calcium receptor antagonist; (E)-3-{3,4-Difluoro-5-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxy]-phenyl}-acrylic acid hydrochloride; bone disorders; hypoparathyroidism, osteosarcoma, periodontal disease, fracture healing, arthritis, Paget's disease, humoral hypercalcemia, osteoporosis
03/16/2006US20060057204 Pharmaceutical compositions containing venlafaxine
03/16/2006US20060057194 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy
03/16/2006US20060053569 Hair dyeing; to obtain strong, unselective colors that show resistance with respect to external agents
03/16/2006CA2580024A1 Therapeutic diphenyl ether ligands
03/16/2006CA2578337A1 P-diaminobenzole-derivatives and dyes containing said compounds
03/15/2006EP1633697A1 Method for the production of substituted 3-aryl-butyl amine compounds
03/15/2006EP1633692A2 Cyclohexyl derivatives as selective estrogen receptor modulators
03/15/2006EP1633310A2 Thiotungstate analogues and uses thereof
03/15/2006EP1359891B1 Primary intermediates for oxidative coloration of hair
03/15/2006EP1175388B1 Spect imaging agents for serotonin transporters
03/15/2006CN1245376C Substituted 2-dialkylamino alkylbiphenyl derivatives
03/14/2006US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
03/14/2006CA2214070C Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
03/14/2006CA2155171C Preparation of amines
03/09/2006US20060052600 Amino-functional chalcones
03/09/2006US20060052315 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
03/09/2006US20060052262 Perfluoropolyether compound and lubricant and magnetic disk using same
03/09/2006US20060051524 Hybrid polymer materials for liquid crystal alignment layers
03/09/2006DE102004042858A1 Spezielle Mischungen von Derivaten des N,N-Bis-(2-hydroxyalkyl)-4-toluidins, deren Herstellung und Verwendung Specific mixtures of derivatives of N, N-bis (2-hydroxyalkyl) -4-toluidine, their preparation and use
03/09/2006DE102004042850A1 p-Diaminobenzol-Derivate und diese Verbindungen enthaltende Färbemittel p-diaminobenzene derivatives and compounds containing colorants
03/08/2006EP1632470A2 Calcium receptor active molecules
03/08/2006EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands
03/08/2006CN1244543C Method for preparing 4-(alkyl)-3-alkoxy-aniline compounds
03/08/2006CN1244542C Aromatic amine derivatives having NOS inhibitory effect
03/07/2006US7009081 zinc and copper catalysts; amino ether amine product has a low level of Cu catalyst contamination; selectivity
03/07/2006US7008954 method of use to treat chronic graft versus host disease, autoimmune diseases, and other specified diseases by administering a tricyclic compound of given structure which includes a pyridyl ring, two phenyl rings and either an amino or oxy group
03/02/2006WO2006023883A2 T type calcium channel inhibitors
03/02/2006WO2006022237A1 Medicament for preventing or treating fatty liver
03/02/2006WO2006021564A1 Novel substituted aryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors
03/02/2006WO2005099312A3 Triarylamine compounds for use as charge transport materials
03/02/2006WO2005079774A3 Management of ophthalmologic disorders, including macular degeneration
03/02/2006WO2005070869A8 Selective hydrogenation of nitrogen containing aromatics
03/02/2006WO2004110364A3 Thiotungstate analogues and uses thereof
03/02/2006US20060047172 oxidative hair colorants; which particularly in combination with the often used p-phenylenediamines would give blue shades and afford oxidation colorants with high resistance to external influences, particularly to frequent washing and sunlight
03/02/2006US20060045830 polyalkylene glycol ether amines absorption liquid for acidic contaminants; scrubbing
03/01/2006EP1630157A1 CaSR ANTAGONIST
03/01/2006EP1628648A1 Deramciclane-fumarate tablets
03/01/2006EP1628647A2 Novel lipids for transfection of nucleic acids
03/01/2006CN1741985A Calcilytic compounds
03/01/2006CN1741984A CaSR antagonist
03/01/2006CN1243722C Method for preparing aminotalan derivative
03/01/2006CN1243721C Substituted amino compounds and their use as substances having analgesic effect
02/2006
02/28/2006US7005539 1,2-bis((2-hydroxy-5-(2-carboxyvinyl))phenoxy)ethane for example; for disease caused by amyloid plaque
02/28/2006US7005538 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; use to treat cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism
02/28/2006US7005441 Fluroescence analysis; controlling transcription factors; bactericides, viricides, anticancer agents, fungicides, antiprotozoa agents
02/23/2006WO2006020348A2 Polymorphs of atomoxetine hydrochloride
02/23/2006US20060041164 liver X receptor LXR agonists; increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, cardiovascular disease, inflammation; 2-(3-{3-[[2-Chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]-2-methyl-propoxy}-phenyl)acetic acid methyl ester
02/23/2006US20060040979 3-Aryl-2-hydroxypropionic acid derivative I
02/23/2006DE102004034619A1 Substituierte Aminoverbindungen als 5-HT/NA Uptakehemmer Substituted amino compounds as 5-HT / NA Uptakehemmer
02/23/2006CA2568629A1 Polymorphs of atomoxetine hydrochloride
02/22/2006EP1237874B1 Selective neurokinin antagonists
02/22/2006CN1242983C Phenoxyacetic acid derivatives and medicinal compositions containing the same
02/21/2006US7002042 Cationic liposomes for gene transfer
02/21/2006US7002036 For production of (poly)peptides; comprises Michael-type addition of nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and conversion of ester to amino moiety
02/21/2006US7002010 Process for the preparation of morpholinones as light stabilizers
02/21/2006US7001973 Photostability; weatherproofing
02/21/2006US7001926 Tubulin binding agents and corresponding prodrug constructs
02/21/2006US7001863 Single site-like catalysts
02/16/2006WO2006004976A3 Process for the preparation of atomoxetine hydrochloride
02/16/2006WO2005081778A3 Improved synthesis of severely sterically hindered amino-ether alcohols and diaminopolyalkenyl ethers using a high activity powder catalyst
02/16/2006US20060035980 Thyronamine derivatives and analogs and methods of use thereof
02/16/2006US20060035868 2' Hydroxy-3'-bromo-3,4,4',5-tetramethoxy-(Z)-stilbene; antimitotic agent; inhibits the assembly of tubulin into microtubules; anticarcinogenic: solid tumor cancers, neovascularization; tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and A-4 (extract from willow tree)
02/16/2006US20060035137 Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery
02/16/2006US20060034035 Nonaqueous electrolyte, electrical double-layer capacitors, and nonaqueous electrolyte secondary cells
02/16/2006DE19821348B4 Ethoxylierte Esterquats Ethoxylated ester quats
02/15/2006EP1625133A2 Nitrogen-containing monodentate phosphines and their use in catalysis
02/15/2006EP1625111A2 Thyronamine derivatives and analogs and methods of use thereof
02/15/2006EP1625110A1 Toremifene crystallization method
02/15/2006CN1733703A 3-benzyloxy-4-butylaniline hydrochloride preparation method
02/15/2006CN1733702A 3-ú¿2-methoxyethoxyú®-propylamine production process
02/14/2006US6998508 made by reaction of a terminal epoxy compound with a primary or secondary amine; useful as catalysts for preparing polyurethane foams and as additives to reduce the dynamic surface tension of solutions
02/14/2006CA2250850C Preparation of substituted aromatic amines
02/08/2006EP1622866A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
02/08/2006EP1622860A1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
02/08/2006EP1235776B1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
02/08/2006EP1144348B1 Lta 4 hydrolase inhibitors
02/08/2006CN1732156A Biphenyl derivatives and their use as fungicides
02/07/2006US6995286 Process for preparing isomers of salbutamol
02/07/2006US6994941 Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus
02/02/2006WO2006011469A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
02/02/2006WO2005097203A3 Serum protein conjugates of ion channel modulating compounds and uses thereof
02/02/2006US20060025474 Bisphenyl compounds useful as vitamin D3 receptor agonists
02/02/2006US20060024523 Organic electroluminescence device
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 140